secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2025-01-17T23:59:59+00:00
Accession:  0001005286-25-000028
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifecore to hold special meeting April 10 to remove Series A preferred conversion cap
--------------------------------------------------------------------------------

- Special meeting on April 10, 2025 to vote on removing the 19.99% conversion cap on Series A Convertible Preferred Stock.
- If approved, up to 6,056,284 common shares could be issued upon conversion at the current conversion price.
- No holders have elected to convert as of Jan 17, 2025; company has no plans to raise additional equity capital.
- Board sets record date of Feb 18, 2025 for voting eligibility.
- Proposal needed to comply with Nasdaq Listing Rule 5635(d) regarding issuance over 19.99% of outstanding common.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528625000028/0001005286-25-000028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528625000028/lndc-20250117.htm
  HTML page:      https://secwatch.observer/filing/0001005286-25-000028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer